Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$112.19
pos +0.00
+0.00%
Today's Range: 110.50 - 112.43 | CELG Avg Daily Volume: 4,339,100
Last Update: 07/29/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -6.32%
Open: $0.00
Previous Close: $111.26
52 Week Range: $92.98 - $133.59
Oustanding Shares: 774,601,496
Market Cap: 86,182,162,445
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 13 13 13
Moderate Buy 0 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.35 1.41 1.41 1.41
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 46.75
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
46.75 53.90 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.49% -15.10% 57.28%
GROWTH 12 Mo 3 Yr CAGR
Revenue 20.70 0.70 0.19
Net Income -19.90 0.10 0.03
EPS -18.80 0.20 0.06
Earnings for CELG:
EBITDA 2.96B
Revenue 9.26B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $1.30 $1.37 $5.09 $6.31
Number of Analysts 3 3 2 3
High Estimate $1.32 $1.39 $5.11 $6.38
Low Estimate $1.29 $1.35 $5.06 $6.22
Prior Year $1.12 $1.00 $4.08 $5.09
Growth Rate (Year over Year) 16.07% 37.00% 24.63% 24.16%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

bullishCelgene estimates, target boosted at Leerink

Jul 29, 2016 | 8:00 AM EDT
Shares of CELG now seen reaching $135, according to Leerink Partners. Estimates also upped, given a recovery in operating momentum.
By

Doug Kass

 | Jul 26, 2016 | 9:30 AM EDT
Continuing Oil Weakness. Crude is trading at $42.62 as I write this, down $0.71 this morning. U.S. Dollar Strength. The greenback's recent firmness is continuing this morning. A Flattening Yield Curve. A yield curve that's flattening out
By

Anders Keitz

 | Jul 26, 2016 | 8:30 AM EDT
Anheuser-Busch increases its offer for SABMiller after Brexit while the Federal Reserve prepares for action against Goldman Sachs.
By

Doug Kass

 | Jul 26, 2016 | 8:30 AM EDT
"Beware of false prophets, who come to you in sheep's clothing but inwardly are ravenous wolves." -- Matthe
By

Guy Ortmann

 | Jul 25, 2016 | 2:03 PM EDT
Chipotle, Wendy's on the bull side and gold stocks on the bear side.
By

Bret Jensen

 | Jul 25, 2016 | 11:52 AM EDT
The market continues to trade lower as we late morning, with Tobira Therapeutics (TBRA) serving as the "disaster du jour" in the small-cap biotech space.
By

Bret Jensen

 | Jul 12, 2016 | 11:00 AM EDT
A look at who will be up and who will down this earnings season.
By

Jim Cramer

 | Jul 11, 2016 | 10:40 AM EDT
They need to do something that makes them stand out as stocks you want to own, not avoid.
By

James Passeri

 | Jul 8, 2016 | 3:33 PM EDT
Shareholders could be in for a surprise if an upcoming drug for pediatric Crohn's gains FDA approval.
By

Bret Jensen

 | Jul 7, 2016 | 12:13 PM EDT

From Celgene to Ford, these names look promising.

Market continues to be mixed.  Oil having a rare up day of late, but still up less th...
My colleague Suz Smith (RM contributor) often talk about different trade scenarios and str...
Thursday's Philadelphia Inquirer reported that the average requested increase for individu...
Markets set to open slightly lower as second quarter GDP comes in at a much lower than exp...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.